← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1982-12-16

Drug application

FDA Application #

ANDA062402

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

Nystatin

Active ingredients

NYSTATIN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

WATSON LABS

First approval

1982-12-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown